tiprankstipranks
Trending News
More News >
Celon Pharma SA (PL:CLN)
:CLN
Poland Market
Advertisement

Celon Pharma SA (CLN) Income Statement

Compare
0 Followers

Celon Pharma SA Income Statement

Last quarter (Q2 2025), Celon Pharma SA's total revenue was zł56.60M, an increase of 5.63% from the same quarter last year. In Q2, Celon Pharma SA's net income was zł-32.76M. See Celon Pharma SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
zł 176.62Mzł 213.92Mzł 161.91Mzł 196.09Mzł 157.45M
Gross Profit
zł 113.45Mzł 147.10Mzł 95.45Mzł 134.37Mzł 107.26M
Operating Expenses
zł 150.26Mzł 174.34Mzł 14.12Mzł 144.82Mzł 124.48M
Depreciation and Amortization
zł 51.86Mzł 50.02Mzł 44.09Mzł 41.34Mzł 34.54M
EBITDA
zł 14.96Mzł 32.71Mzł 9.32Mzł 27.81Mzł 30.37M
Operating Income
zł -36.81Mzł -27.24Mzł -69.76Mzł -10.45Mzł -3.67M
Other Income/Expenses
zł -2.56Mzł 7.27Mzł 890.00Kzł -4.63Mzł -1.92M
Pretax Income
zł -39.37Mzł -19.97Mzł -36.45Mzł -15.09Mzł -5.59M
Net Income
zł -34.45Mzł -28.12Mzł -39.28Mzł -11.61Mzł -917.00K
Per Share Metrics
Basic EPS
zł -0.66zł -0.55zł -0.77zł -0.25zł -0.02
Diluted EPS
zł -0.66zł -0.55zł -0.77zł -0.25zł -0.02
Weighted Average Shares Outstanding
52.51M 51.06M 51.02M 46.68M 45.00M
Weighted Average Shares Outstanding (Diluted)
52.52M 51.06M 51.02M 46.68M 45.00M
Currency in PLN

Celon Pharma SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis